New England Capital Financial Advisors’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$24K Hold
97
0.01% 187
2026
Q1
$19.4K Hold
97
0.01% 198
2025
Q4
$20K Hold
97
0.01% 196
2025
Q3
$17.3K Hold
97
0.01% 203
2025
Q2
$15.6K Hold
97
0.01% 203
2025
Q1
$16.4K Hold
97
0.01% 197
2024
Q4
$16.1K Buy
97
+1
+1% +$171 0.01% 198
2024
Q3
$16.5K Hold
96
0.01% 197
2024
Q2
$14.8K Hold
96
0.01% 206
2024
Q1
$14.8K Hold
96
0.01% 200
2023
Q4
$15.2K Hold
96
0.01% 204
2023
Q3
$14.1K Hold
96
0.01% 202
2023
Q2
$14.7K Hold
96
0.01% 192
2023
Q1
$14.9K Hold
96
0.01% 210
2022
Q4
$15.5K Buy
+96
New +$14.2K 0.01% 211

Other funds holding FBT

New England Capital Financial Advisors's FBT Position: Q2 2026 in Review

New England Capital Financial Advisors held its First Trust NYSE Arca Biotechnology Index Fund (FBT) position steady in Q2 2026 at 97 shares worth $24K. The position accounts for 0.01% of the portfolio, ranked #187.

New England Capital Financial Advisors first reported a position in FBT in Q4 2022 and has held it in 15 quarters since. 109 funds tracked by Wall St. Rank hold FBT as of Q2 2026.

  • New England Capital Financial Advisors held 97 shares of First Trust NYSE Arca Biotechnology Index Fund worth $24K as of Q2 2026.
  • New England Capital Financial Advisors left its First Trust NYSE Arca Biotechnology Index Fund share count unchanged in Q2 2026.
  • First Trust NYSE Arca Biotechnology Index Fund made up 0.01% of New England Capital Financial Advisors's portfolio in Q2 2026, its #187 holding.
  • New England Capital Financial Advisors first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2022 and has held it in 15 quarters since.
  • 109 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2026.

Based on New England Capital Financial Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.